Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CASPOFUNGIN Cause Condition aggravated? 109 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Condition aggravated have been filed in association with CASPOFUNGIN (CASPOFUNGIN ACETATE). This represents 2.9% of all adverse event reports for CASPOFUNGIN.

109
Reports of Condition aggravated with CASPOFUNGIN
2.9%
of all CASPOFUNGIN reports
58
Deaths
50
Hospitalizations

How Dangerous Is Condition aggravated From CASPOFUNGIN?

Of the 109 reports, 58 (53.2%) resulted in death, 50 (45.9%) required hospitalization, and 30 (27.5%) were considered life-threatening.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CASPOFUNGIN. However, 109 reports have been filed with the FAERS database.

What Other Side Effects Does CASPOFUNGIN Cause?

Drug ineffective (1,060) Off label use (325) Product use in unapproved indication (257) Multiple organ dysfunction syndrome (215) Drug resistance (194) Septic shock (165) Aspergillus infection (154) Drug reaction with eosinophilia and systemic symptoms (136) Systemic mycosis (129) Pyrexia (128)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) INFLIXIMAB-DYYB (10,275) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627)

Which CASPOFUNGIN Alternatives Have Lower Condition aggravated Risk?

CASPOFUNGIN vs CATEQUENTINIB CASPOFUNGIN vs CC-4047 CASPOFUNGIN vs CEDAZURIDINE\DECITABINE CASPOFUNGIN vs CEDIRANIB CASPOFUNGIN vs CEFACLOR

Related Pages

CASPOFUNGIN Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated CASPOFUNGIN Demographics